Diabetes treating ‘SGLT2 inhibitors’ named among top advances for preventing heart disease
Summary: SGLT2 inhibitors, a widely heralded class of diabetes drugs, were shown to significantly lower the rates of heart failure and death in the CVD-REAL study. [This article first appeared on LongevityFacts. Author: Brady Hartman. ] The new SGLT2 inhibitors are a class of diabetes treatments shown in observational studies to have lower rates of heart failure and death when compared to other glucose-lowering… Continue reading "Diabetes treating ‘SGLT2 inhibitors’ named among top advances for preventing heart disease"